Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

The Role of Docosahexaenoic Acid (DHA) on Cognitive Functions in Psychiatric Disorders.

Ciappolino V, Mazzocchi A, Botturi A, Turolo S, Delvecchio G, Agostoni C, Brambilla P.

Nutrients. 2019 Apr 2;11(4). pii: E769. doi: 10.3390/nu11040769.

2.

The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.

Buoli M, Serati M, Botturi A, Altamura AC.

Drugs R D. 2018 Mar;18(1):1-5. doi: 10.1007/s40268-017-0224-6. Review.

3.

Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease.

Chiapparini L, Cavalli G, Langella T, Venerando A, De Luca G, Raspante S, Marotta G, Pollo B, Lauria G, Cangi MG, Gerevini S, Botturi A, Pareyson D, Dagna L, Salsano E.

J Neurol. 2018 Feb;265(2):273-284. doi: 10.1007/s00415-017-8692-8. Epub 2017 Dec 4.

PMID:
29204962
4.

Neuropsychiatric Burden in Huntington's Disease.

Paoli RA, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, Zugno E, Caletti E.

Brain Sci. 2017 Jun 16;7(6). pii: E67. doi: 10.3390/brainsci7060067. Review.

5.

Helping patients to reduce tobacco consumption in oncology: a narrative review.

Lucchiari C, Masiero M, Botturi A, Pravettoni G.

Springerplus. 2016 Jul 20;5(1):1136. doi: 10.1186/s40064-016-2798-9. eCollection 2016. Review.

6.

Reversible Valproate Induced Pisa Syndrome and Parkinsonism in a Neuro-Oncology Patient with Depression and Epilepsy.

Botturi A, Silvani A, Pravettoni G, Paoli RA, Lucchiari C.

Case Rep Neurol. 2016 Jun 6;8(2):115-9. doi: 10.1159/000446643. eCollection 2016 May-Aug.

7.

Experiencing brain cancer: what physicians should know about patients.

Lucchiari C, Botturi A, Manzini L, Masiero M, Pravettoni G.

Ecancermedicalscience. 2015 Nov 12;9:591. doi: 10.3332/ecancer.2015.591. eCollection 2015.

8.

Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL): a new report of an Italian woman and review of the literature.

Bock V, Botturi A, Gaviani P, Lamperti E, Maccagnano C, Piccio L, Silvani A, Salmaggi A.

J Neurol Sci. 2013 Mar 15;326(1-2):115-9. doi: 10.1016/j.jns.2013.01.021. Epub 2013 Feb 9. Review.

PMID:
23399524
9.

Multidrug resistance proteins expression in glioma patients with epilepsy.

Calatozzolo C, Pollo B, Botturi A, Dinapoli L, Carosi M, Salmaggi A, Maschio M.

J Neurooncol. 2012 Oct;110(1):129-35. doi: 10.1007/s11060-012-0946-9. Epub 2012 Jul 26.

PMID:
22832898
10.

Bevacizumab at recurrence in high-grade glioma.

Salmaggi A, Gaviani P, Botturi A, Lamperti E, Simonetti G, Ferrari D, Silvani A.

Neurol Sci. 2011 Nov;32 Suppl 2:S251-3. doi: 10.1007/s10072-011-0799-6. Review.

PMID:
21987287
11.

The burden of brain tumor: a single-institution study on psychological patterns in caregivers.

Finocchiaro CY, Petruzzi A, Lamperti E, Botturi A, Gaviani P, Silvani A, Sarno L, Salmaggi A.

J Neurooncol. 2012 Mar;107(1):175-81. doi: 10.1007/s11060-011-0726-y. Epub 2011 Oct 4.

PMID:
21968946
12.

Recurrent brain tumour: the impact of illness on patient's life.

Lamperti E, Pantaleo G, Finocchiaro CY, Silvani A, Botturi A, Gaviani P, Sarno L, Salmaggi A.

Support Care Cancer. 2012 Jun;20(6):1327-32. doi: 10.1007/s00520-011-1220-y. Epub 2011 Jul 3.

PMID:
21725828
13.

Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas.

Silvani A, Gaviani P, Fiumani A, Scaioli V, Lamperti E, Eoli M, Botturi A, Salmaggi A.

J Neurooncol. 2009 Oct;95(1):61-64. doi: 10.1007/s11060-009-9890-8. Epub 2009 Apr 21.

PMID:
19381446
14.

Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments.

Erbetta A, Salmaggi A, Sghirlanzoni A, Silvani A, Potepan P, Botturi A, Ciceri E, Bruzzone MG.

Neurol Sci. 2008 Jun;29(3):131-7. doi: 10.1007/s10072-008-0924-3. Epub 2008 Jul 9.

PMID:
18612759
15.

Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?

Boiardi A, Silvani A, Eoli M, Lamperti E, Salmaggi A, Gaviani P, Fiumani A, Botturi A, Falcone C, Solari A, Filippini G, Di Meco F, Broggi G.

J Neurooncol. 2008 May;88(1):105-13. doi: 10.1007/s11060-008-9540-6. Epub 2008 Feb 19.

PMID:
18283418
16.

A novel mutation in the GFAP gene in a familial adult onset Alexander disease.

Salmaggi A, Botturi A, Lamperti E, Grisoli M, Fischetto R, Ceccherini I, Caroli F, Boiardi A.

J Neurol. 2007 Sep;254(9):1278-80. Epub 2007 Aug 16. No abstract available.

PMID:
17703343
17.

Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.

Silvani A, Lamperti E, Gaviani P, Eoli M, Fiumani A, Salmaggi A, Falcone C, Filippini G, Botturi A, Boiardi A.

J Neurooncol. 2008 Apr;87(2):143-51. Epub 2007 Jun 19. Erratum in: J Neurooncol. 2008 Apr;87(2):153. J Neurooncol. 2008 Aug;89(1):119.

PMID:
17576523
18.

Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma.

Boiardi A, Bartolomei M, Silvani A, Eoli M, Salmaggi A, Lamperti E, Milanesi I, Botturi A, Rocca P, Bodei L, Broggi G, Paganelli G.

J Neurooncol. 2005 Apr;72(2):125-31.

PMID:
15925992
19.

The densitometric physical fractionator for counting neuronal populations: application to a mouse model of familial amyotrophic lateral sclerosis.

Ciavarro GL, Calvaresi N, Botturi A, Bendotti C, Andreoni G, Pedotti A.

J Neurosci Methods. 2003 Oct 15;129(1):61-71. Erratum in: J Neurosci Methods. 2013 Feb 15;213(1):151.

PMID:
12951233

Supplemental Content

Loading ...
Support Center